Reports by Industry
Reports by Company
- Company Analysis(173)
- Company Profile(60)
Low Wages & Govt Support Pushing China Ahead of other Asia-Pacific Biotech Markets
Nov 13, 2008
We have recently released a new research report, “Asia Pacific Biotechnology Market (2008-2012)”, which says that the Chinese biotechnology market is expected to grow at a CAGR of over 23% during 2007-2012. This will enable the country to represent around 25% of the Asia Pacific biotech market revenue by 2012.
The report has identified lower wages in China compared to other Asian-Pacific countries as the main reason for high growth in the country’s biotechnology market. For instance, wages in China are 10% to 15% lower than that in India, one of the low-cost countries. Moreover, with hire and fire policy, the labor policies in China are more liberal, helping the biotech industry to increase productivity and reduce cost.
The Chinese government strongly supports its biotech industry and has been aggressively investing in the industry to foster growth, says the report. Apparently, the annual investments by the government surged at a CAGR of 86.12% during 2001-2005 to US$ 1.2 Billion in 2005 from US$ 100 Million in 2001. In addition, we expect that the investment will rise to US$ 8.8 Billion by the end of 2010 as the government intends to make China one of the leading biotech markets in the world.
China is just one of the many Asia-Pacific countries discussed in the “Asia-Pacific Biotechnology Market (2008-2012)”. The report provides comprehensive overview on the biotechnology market of countries like Japan, Taiwan and Singapore. It highlights the fact that Asia-Pacific biotechnology markets differ from each other remarkably in terms of infrastructure, talent pool, size, funding, growth, and potential as an outsourcing destination. It gives valuable information along with statistical data to pharmaceutical & biotechnology companies and investors planning to invest in these markets, helping them to plan their strategies according to the individual market.
The report also provides information on the market size, segmentation, structure, growth, future prospects, success and risk factors, and evolving trends in technology development.
For more information visit: http://www.rncos.com/Report/IM138.htm
Related Releases are as follows:
- Growing Inclination of Biopharmaceutical Companies towards Bi-Specific Antibodies
- Potential Blockbuster Drugs Projected to Drive Global Immuno-Oncology Market
- Immuno-Oncology Market Global Forecast to 2022
- Global Antibody Drug Conjugate Drug Sales, Pipeline Analysis (By Phase, Linker, Technology, and Indication) & Market Forecast to 2023
- Global Bi-Specific Antibodies Market Forecast 2022
Media Citation
- testtest
19 Jan, 2024 - Yourstory.com News @ Foodtech startup Swiggy launches Health Hub in Chennai
23 Mar, 2021 - Yourstory.com News @ Zomato forays into dietary supplements, makes its own 'made in India' brand
16 Mar, 2021 - View more
get in touch
Copyright © 2014, RNCOS, 2002-2014
About Us
Terms & Policy
Contact